Stay updated with breaking news from Comorbidity Burden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss a complex chronic GVHD case post-allogeneic transplant. The panel explores third-line options, including belumosudil, ibrutinib, photopheresis, and clinical trials, emphasizing shared decision-making and the need for well-designed trials in guiding treatment decisions.
/PRNewswire/ -- Novo Nordisk today announced the upcoming presentation of new data that helps reinforce the company's commitment to driving change and...
Meeting plenary session to feature 12-Month data from MIRROR randomized controlled trial of KRYSTEXXA (pegloticase) injection with methotrexate - Horizon Therapeutics plc (Nasdaq: HZNP) today announced